N-Acetylcysteine is associated with changes in functional connectivity in patients with Parkinson's disease

Key Points

• Changes in functional connectivity were observed with n-acetylcysteine treatment in Parkinson's disease.
• Significant alterations in brain activity patterns were noted, with implications for symptom management.
• Assessment involved neurological testing and brain imaging techniques to evaluate functional connectivity.
• This study highlights the need for further research into n-acetylcysteine's benefits in managing Parkinson's disease.